ArticleBone marrow transplantation2006

Folic acid supplementation during methotrexate immunosuppression is not associated with early toxicity, risk of acute graft-versus-host disease or relapse following hematopoietic transplantation.

K Robien et al.PubMed ↗Publisher ↗

No numbers read from the abstract.